
News|Articles|April 20, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 20, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of today, April 20, 2022, at 6:22 PM, EDT:
45.5% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
• 66% of total US population
• 70.1% of US population aged ≥5 years
• 74.4% of US population aged ≥12 years
• 75.9% of US population aged ≥18 years
• 89.8% of US population aged ≥65 years
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, April 20, 2022 at 6:20 PM, EDT, there have been:
• 80 795 951 confirmed cases and
• 990 143 deaths
• 990 143 deaths
In the past 28 days, the 3 states with the most new cases are:
1. New York: 123 841
2. Texas: 96 987
3. California:90 395
2. Texas: 96 987
3. California:90 395
Deaths: California has the highest number of deaths due to COVID-19 with 89 833 reported fatalities, followed by Texas with 87 929 and Florida with 73 738.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 506 627 123 confirmed cases, 6 206 609 deaths, and 11 202 214 718 vaccine doses administered.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Clears First At-Home Brain-Stimulation Device for Major Depression
2
Retatrutide Achieves Up to 28.7% Weight Loss and Marked Knee Pain Reduction in Phase 3 TRIUMPH-4 Trial
3
Two Global Phase 3 Trials Confirm Efficacy of Rocatinlimab for People With Moderate-to-Severe Atopic Dermatitis
4
ADA Publishes 2026 Standards of Care With Updates to Sections on Technology, Obesity, Cardiometabolic Disease Management
5





















































































































































































































































































